Metastatic Colorectal Cancers Completed Phase 3 Trials for Leucovorin (DB00650)

Also known as: Colorectal Cancer Metastatic / Metastatic Colorectal Cancer / Metastatic Colorectal Cancer (MCRC) / Cancer - Metastatic Colorectal / Colorectal Cancer, Metastatic

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03288987Comparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal CancerTreatment
NCT01228734A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type PatientsTreatment
NCT00252564Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerTreatment
NCT01878422Sequential Treatment Strategy for Metastatic Colorectal CancerTreatment
NCT00339183Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy AloneTreatment
NCT00145314FLOX in Combination With Cetuximab in First-line Treatment of Colorectal CancerTreatment
NCT00399035Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerTreatment
NCT00457691Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal CancerTreatment
NCT01030042Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic PatientsTreatment
NCT01219920FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal CancerTreatment
NCT01571284Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based RegimenTreatment
NCT01670721Colorectal Cancer MetastaticTreatment